VivoSim Labs
VIVS
94 hedge funds and large institutions have $29.8M invested in VivoSim Labs in 2019 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 21 increasing their positions, 28 reducing their positions, and 24 closing their positions.
52% more capital inflows, than outflows
Capital inflows: $13.5M | Capital outflows: $8.87M
0.89% more ownership
Funds ownership: 42.96% → 43.85% (+0.89%)
5% less call options, than puts
Call options by funds: $36K | Put options by funds: $38K
15% less funds holding
Funds holding: 110 → 94 (-16)
25% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 28
50% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 24
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nikko Asset Management Americas
New York
|
+$7.02M |
| 2 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$1.67M |
| 3 |
Renaissance Technologies
New York
|
+$1.31M |
| 4 |
ARK Investment Management
St. Petersburg,
Florida
|
+$893K |
| 5 |
Millennium Management
New York
|
+$791K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$4.02M |
| 2 |
State Street
Boston,
Massachusetts
|
-$1.34M |
| 3 |
D.E. Shaw & Co
New York
|
-$511K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$331K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$319K |
VIVS Hedge Fund Activity: Q2 2019 in Review
94 of the 4,626 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q2 2019, worth a combined $29.8M — down 41% from $50.9M a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of VIVS and 12 opened new positions — a net loss of 12 holders — while 28 trimmed existing stakes and 21 added.
The largest buyer was Nikko Asset Management Americas, adding an estimated $7.02M. The largest seller was BlackRock, cutting an estimated $4.02M.
- 94 institutional investors held VivoSim Labs (VIVS) as of Q2 2019, down from 110 in Q1 2019.
- Funds reported $29.8M of VivoSim Labs stock for Q2 2019, down 41% quarter-over-quarter.
- 12 funds opened new VivoSim Labs positions in Q2 2019 and 24 closed out, a net change of -12 holders.
- The largest VivoSim Labs buyer in Q2 2019 was Nikko Asset Management Americas, an estimated $7.02M added.
- The largest VivoSim Labs seller in Q2 2019 was BlackRock, an estimated $4.02M sold.
Based on aggregated 13F filings for Q2 2019.